Streetbeat News

Stock Prices

ODD

ODDITY Tech Ltd's shares are up by 15% following the company's preliminary Q3 FY23 results, which predict revenue growth to surpass its guidance. The company has raised its net revenue growth outlook to 29.0%-31.0% and gross margin to 68.5%. It also expects an adjusted EBITDA margin within 21.0%-21.5%. The company's CEO attributes these strong financial results to the power of their platform and their ability to consistently deliver high growth and profitability.

Portfolio Pulse from Lekha Gupta

October 03, 2023 | 11:06 am

ODD

ODDITY Tech has reported strong preliminary Q3 results, which will enable the company to achieve a net revenue growth of at least 58% in the first three quarters of 2023. As a result, the company's shares are trading higher.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:04 am

MRK

PDSB

PDS Biotechnology Corporation (NASDAQ:PDSB) has announced updated interim data from the VERSATILE-002 Phase 2 clinical trial evaluating PDS0101 in combination with Merck's (NYSE:MRK) KEYTRUDA in patients with HPV16-positive head and neck squamous cell carcinoma. The 24-month survival rate was 74% in immune checkpoint inhibitor naive patients.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:03 am

LIFW

OPTT

OXBR

VANI

Insiders at four penny stocks, Vivani Medical, Inc. (VANI), MSP Recovery, Inc. (LIFW), Oxbridge Re Holdings Limited (OXBR), and Ocean Power Technologies, Inc. (OPTT), have recently made significant purchases. This could indicate their confidence in the companies' prospects despite recent losses reported by all four companies.

Portfolio Pulse from Lisa Levin

October 03, 2023 | 10:59 am

ALXO

ALX Oncology has released interim Phase 2 data from its ASPEN-06 trial of evorpacept in advanced HER2-positive gastric cancer, which has led to a rise in the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 10:56 am

ALXO

CALM

MKC

NVDA

QQQ

SPY

The S&P 500 and Nasdaq futures are wavering as the market turns its focus to the JOLTS data. Analysts from LPL Financial suggest that expecting a strong Q4 this year could be tricky due to factors such as a potential government shutdown, high interest rates, and a strong dollar. The SPDR S&P 500 ETF Trust (SPY) and the Invesco QQQ ETF (QQQ) saw slight increases in premarket trading. Stocks in focus include ALX Oncology Holdings (ALXO), Nvidia Corp (NVDA), McCormick & Company (MKC), and Cal-Maine Foods (CALM).

Portfolio Pulse from Shanthi Rexaline

October 03, 2023 | 10:54 am

STLA

VWAGY

President Biden's proposal to increase fuel efficiency norms by 2032 could lead to penalties of $6.5 billion for General Motors (GM), $3 billion for Stellantis (STLA), and $1 billion each for Ford (F) and Volkswagen (VWAGY). The American Automotive Policy Council, representing these companies, has expressed concerns about the Department of Energy's plans to alter the Petroleum Equivalency Factor, which could lead to higher compliance costs for U.S. carmakers.

Portfolio Pulse from Shivani Kumaresan

October 03, 2023 | 10:52 am

LLY

PNT

Eli Lilly and Company (LLY) has agreed to acquire Point Biopharma (PNT) for $12.50 per share in cash, totaling approximately $1.4 billion.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 10:46 am

TSLA

Morgan Stanley analyst Adam Jonas maintains a positive outlook on Tesla Inc (NASDAQ:TSLA) despite the company's Q3 delivery figures falling below estimates. Jonas has maintained an 'overweight' rating on Tesla stock with a price target of $400, based on expectations that Tesla's supercomputer, Dojo, could unlock new markets for the EV giant. Despite challenges in the rate of EV adoption and potential shifts in sourcing from China, Jonas believes Tesla can address these issues.

Portfolio Pulse from Anan Ashraf

October 03, 2023 | 10:38 am

ADRT

Ault Disruptive Technologies Corporation, a special purpose acquisition company, has announced that the NYSE American has accepted its business plan to regain compliance with the Exchange's continued listing standards. The company was previously notified of its non-compliance with the standards, which require a listed company to maintain a minimum of 200,000 shares publicly held and a minimum of 300 public stockholders on a continuous basis.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 10:36 am